GleamWall
中文EN

LDDD Longduoduo Co Ltd

Services-Health Services · OTC · SEC CIK 1892316 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY-71.6%
TTM net income YoY-316.7%
TTM EPS YoY-321.4%
Revenue 3-yr CAGR-38.1%
Net income 3-yr CAGR—

Margins

Gross margin99.1%
Operating margin-88.5%
Net margin-78.3%
FCF margin—
EBITDA margin-79.1%

Returns

ROE-132.6%
ROA-53.9%
ROIC (approx.)—
Asset turnover0.69x

Leverage & solvency

Liabilities / assets80.2%
Debt / equity0.00x
Current ratio1.07x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.44x
Accruals ratio-30.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-09-302026Q4*2026-06-302026Q32026-03-312026Q22025-12-312026Q12025-09-302025Q4*2025-06-302025Q32025-03-312025Q22024-12-31
Income statement
Revenue$17,595$631,036$187,392$345,265$658,764$940,376$777,720$1.78M
Cost of revenue—$1,640$3,337$5,271$6,710$9,598$20,444$28,781
Gross profit$17,595$629,396$184,055$339,994$652,054$930,778$757,276$1.75M
SG&A expense$513,930$701,527$381,498$619,187$736,468$799,778$876,095$1.14M
Operating income-$496,335-$72,131-$197,443-$279,193-$84,414$131,000-$118,819$602,574
Pretax income-$478,845-$67,537-$189,966-$274,225-$44,088$282,093-$116,236$607,995
Income tax-$4,678-$704$41$20$67,094$115,608$84$106,396
Net income-$436,962-$62,974-$166,208-$258,495-$90,954$163,145-$109,104$463,697
EBITDA-$468,409-$43,982-$169,588-$251,955-$56,992$158,087-$91,158$655,118
EPS (basic)-0.01—-0.01-0.01-0.00—-0.000.02
EPS (diluted)-0.01—-0.01-0.01-0.00—-0.000.02
Weighted avg. shares (diluted)30.02M—30.02M30.02M30.02M—30.01M30.01M
Balance sheet
Cash & equivalents$1.01M$1.59M$1.22M$1.54M$1.25M$1.64M$1.46M$1.62M
Current assets$1.29M$1.78M$1.44M$1.76M$1.52M$1.81M$1.69M$1.83M
PP&E, net$187,751$213,025$237,358$261,850$284,387$280,003$300,179$325,426
Total assets$1.53M$2.06M$1.75M$2.10M$1.90M$2.13M$2.03M$2.20M
Current liabilities$1.21M$1.28M$932,776$1.12M$677,352$830,464$901,763$972,258
Total liabilities$1.23M$1.31M$957,123$1.14M$700,555$830,464$920,639$990,851
Shareholders' equity$288,107$703,691$736,924$880,361$1.11M$1.18M$998,047$1.09M
Shares outstanding30.02M30.02M30.02M30.02M30.02M30.02M30.02M30.01M
Cash flow statement
Operating cash flow-$615,031$274,772-$332,309$268,612-$374,184$184,215-$187,111$815,259
Capital expenditure—$275$275$140$29,948$29,921-$26,852-$125
Free cash flow—$274,497-$332,584$268,472-$404,132$154,294-$160,259$815,384
Investing cash flow—-$275-$275-$140-$29,948-$29,921$26,852$125
Depreciation & amortization$27,926$28,149$27,855$27,238$27,422$27,087$27,661$52,544

Free plan shows the latest 8 periods; Pro shows all 21 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.